Cancer Risk Reduction
Obesity is linked to 13 types of cancer. Weight loss from GLP-1s may reduce cancer risk, though direct cancer prevention data is still emerging.
Cancer types linked to obesity
13
Risk reduction with weight loss
Significant
Direct GLP-1 data
Emerging
Condition Guide
Cancer Risk Reduction
Weight Loss and Cancer
Obesity increases risk of breast, colon, endometrial, kidney, liver, and other cancers through inflammation and hormonal changes. Weight loss of 10-15% reduces cancer risk. GLP-1-induced weight loss may reduce obesity-related cancer risk. Direct cancer prevention studies are ongoing. Improved metabolic health reduces cancer-promoting inflammation.
Screening
Maintain age-appropriate cancer screening during weight loss. Weight loss may make some screenings easier (mammography). Discuss family history with your provider. SeraVia formulations support overall health.
Frequently Asked Questions
Will GLP-1s reduce my cancer risk?
Weight loss from GLP-1s likely reduces obesity-related cancer risk, though direct prevention studies are ongoing.
SeraVia formulations support overall health and wellness during weight loss for comprehensive risk reduction.
Learn More →Find preventive health and weight management specialists
Compare pricing, reviews, and availability across 18,000+ GLP-1 providers.
Search Providers →Explore all conditions
Learn how GLP-1 medications treat different conditions — from diabetes to PCOS to cardiovascular disease.